TrialAntimicrobial agents and chemotherapy1997

Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.

M Hidalgo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.